ANKARA (Reuters) -Turkey on Friday began administering Pfizer and BioNTech’s COVID-19 shots, introducing a second vaccine in its campaign as new cases reached record highs. Turkey has so far delivered nearly 16.6 million doses of the vaccine developed by China’s Sinovac Biotech, including two shots each for about 7.1 million people and one shot each so far for about 2.4 million people. Emre Yavuz said he and his wife received the Pfizer/BioNTech vaccine because their daughter studies in Europe, which he said may not allow in those who receive the Sinovac vaccine. The total number of cases stood just above 3.4 million as of Friday, with the death toll at 31,892. Turkey currently ranks fifth globally for daily cases based on a seven-day average, according to a Reuters tally.

Source: Egypt Independent April 02, 2021 12:00 UTC